nodes	percent_of_prediction	percent_of_DWPC	metapath
Nelarabine—Hydrocephalus—Carmustine—malignant glioma	0.0517	0.0934	CcSEcCtD
Nelarabine—Hemiparesis—Temozolomide—malignant glioma	0.0225	0.0406	CcSEcCtD
Nelarabine—Status epilepticus—Temozolomide—malignant glioma	0.02	0.0361	CcSEcCtD
Nelarabine—DGUOK—retina—malignant glioma	0.0192	0.104	CbGeAlD
Nelarabine—DGUOK—telencephalon—malignant glioma	0.0177	0.0958	CbGeAlD
Nelarabine—Sensory disturbance—Temozolomide—malignant glioma	0.0152	0.0275	CcSEcCtD
Nelarabine—DGUOK—medulla oblongata—malignant glioma	0.0139	0.0752	CbGeAlD
Nelarabine—DGUOK—Purine metabolism—CAT—malignant glioma	0.0137	0.0561	CbGpPWpGaD
Nelarabine—DGUOK—midbrain—malignant glioma	0.0127	0.0688	CbGeAlD
Nelarabine—DGUOK—spinal cord—malignant glioma	0.0124	0.0671	CbGeAlD
Nelarabine—POLA1—retina—malignant glioma	0.0118	0.0642	CbGeAlD
Nelarabine—Opportunistic infection—Temozolomide—malignant glioma	0.0117	0.0211	CcSEcCtD
Nelarabine—Haemorrhage intracranial—Temozolomide—malignant glioma	0.0115	0.0207	CcSEcCtD
Nelarabine—ADA—C-MYB transcription factor network—YEATS4—malignant glioma	0.0111	0.0456	CbGpPWpGaD
Nelarabine—Grand mal convulsion—Carmustine—malignant glioma	0.0102	0.0185	CcSEcCtD
Nelarabine—Altered state of consciousness—Temozolomide—malignant glioma	0.0102	0.0184	CcSEcCtD
Nelarabine—DGUOK—central nervous system—malignant glioma	0.01	0.0544	CbGeAlD
Nelarabine—DGUOK—cerebellum—malignant glioma	0.00982	0.0532	CbGeAlD
Nelarabine—Cerebral haemorrhage—Carmustine—malignant glioma	0.0088	0.0159	CcSEcCtD
Nelarabine—Adenosine monophosphate—PIM1—malignant glioma	0.00871	0.488	CrCbGaD
Nelarabine—Cerebral haemorrhage—Temozolomide—malignant glioma	0.0085	0.0154	CcSEcCtD
Nelarabine—DCK—embryo—malignant glioma	0.00826	0.0448	CbGeAlD
Nelarabine—Febrile neutropenia—Carmustine—malignant glioma	0.0081	0.0146	CcSEcCtD
Nelarabine—Transaminases increased—Carmustine—malignant glioma	0.00801	0.0145	CcSEcCtD
Nelarabine—DGUOK—brain—malignant glioma	0.00797	0.0432	CbGeAlD
Nelarabine—Febrile neutropenia—Temozolomide—malignant glioma	0.00783	0.0141	CcSEcCtD
Nelarabine—Encephalopathy—Carmustine—malignant glioma	0.00759	0.0137	CcSEcCtD
Nelarabine—Aphasia—Carmustine—malignant glioma	0.00751	0.0136	CcSEcCtD
Nelarabine—DCK—retina—malignant glioma	0.0073	0.0396	CbGeAlD
Nelarabine—Cyst—Carmustine—malignant glioma	0.00729	0.0132	CcSEcCtD
Nelarabine—Aphasia—Temozolomide—malignant glioma	0.00726	0.0131	CcSEcCtD
Nelarabine—Burning sensation—Carmustine—malignant glioma	0.00701	0.0127	CcSEcCtD
Nelarabine—DGUOK—Nucleotide metabolism—CAT—malignant glioma	0.0069	0.0282	CbGpPWpGaD
Nelarabine—DCK—telencephalon—malignant glioma	0.00672	0.0364	CbGeAlD
Nelarabine—Adenosine triphosphate—ACVR1—malignant glioma	0.00642	0.36	CrCbGaD
Nelarabine—POLA1—cerebellum—malignant glioma	0.00605	0.0328	CbGeAlD
Nelarabine—Rigors—Temozolomide—malignant glioma	0.00577	0.0104	CcSEcCtD
Nelarabine—ADA—central nervous system—malignant glioma	0.00575	0.0311	CbGeAlD
Nelarabine—Petechiae—Temozolomide—malignant glioma	0.00572	0.0103	CcSEcCtD
Nelarabine—ADA—C-MYB transcription factor network—PIM1—malignant glioma	0.00571	0.0233	CbGpPWpGaD
Nelarabine—Speech disorder—Carmustine—malignant glioma	0.00566	0.0102	CcSEcCtD
Nelarabine—ADA—Validated transcriptional targets of TAp63 isoforms—PLK1—malignant glioma	0.00552	0.0226	CbGpPWpGaD
Nelarabine—Speech disorder—Temozolomide—malignant glioma	0.00547	0.0099	CcSEcCtD
Nelarabine—Disturbance in attention—Temozolomide—malignant glioma	0.00543	0.00982	CcSEcCtD
Nelarabine—DCK—medulla oblongata—malignant glioma	0.00528	0.0286	CbGeAlD
Nelarabine—Hyperbilirubinaemia—Temozolomide—malignant glioma	0.00518	0.00936	CcSEcCtD
Nelarabine—Gait disturbance—Carmustine—malignant glioma	0.00499	0.00902	CcSEcCtD
Nelarabine—Coordination abnormal—Carmustine—malignant glioma	0.00496	0.00897	CcSEcCtD
Nelarabine—POLA1—brain—malignant glioma	0.00492	0.0267	CbGeAlD
Nelarabine—DCK—midbrain—malignant glioma	0.00483	0.0262	CbGeAlD
Nelarabine—Gait disturbance—Temozolomide—malignant glioma	0.00482	0.00872	CcSEcCtD
Nelarabine—Coordination abnormal—Temozolomide—malignant glioma	0.00479	0.00867	CcSEcCtD
Nelarabine—ADA—Validated transcriptional targets of deltaNp63 isoforms—TOP2A—malignant glioma	0.00477	0.0195	CbGpPWpGaD
Nelarabine—DCK—spinal cord—malignant glioma	0.00471	0.0255	CbGeAlD
Nelarabine—Depressed level of consciousness—Carmustine—malignant glioma	0.0047	0.0085	CcSEcCtD
Nelarabine—ADA—Validated transcriptional targets of TAp63 isoforms—PML—malignant glioma	0.00467	0.0191	CbGpPWpGaD
Nelarabine—DCK—Retinoblastoma (RB) in Cancer—STMN1—malignant glioma	0.00459	0.0188	CbGpPWpGaD
Nelarabine—Neuropathy—Carmustine—malignant glioma	0.00457	0.00827	CcSEcCtD
Nelarabine—ADA—brain—malignant glioma	0.00456	0.0247	CbGeAlD
Nelarabine—ADA—Purine metabolism—CAT—malignant glioma	0.00456	0.0186	CbGpPWpGaD
Nelarabine—Depressed level of consciousness—Temozolomide—malignant glioma	0.00455	0.00822	CcSEcCtD
Nelarabine—ADA—p73 transcription factor network—HEY2—malignant glioma	0.00449	0.0184	CbGpPWpGaD
Nelarabine—Coma—Carmustine—malignant glioma	0.00445	0.00805	CcSEcCtD
Nelarabine—Neuropathy—Temozolomide—malignant glioma	0.00442	0.00799	CcSEcCtD
Nelarabine—Neoplasm—Carmustine—malignant glioma	0.0044	0.00796	CcSEcCtD
Nelarabine—ADA—Validated transcriptional targets of deltaNp63 isoforms—FBXW7—malignant glioma	0.00436	0.0178	CbGpPWpGaD
Nelarabine—ADA—Validated transcriptional targets of deltaNp63 isoforms—BDKRB2—malignant glioma	0.00428	0.0175	CbGpPWpGaD
Nelarabine—Neoplasm—Temozolomide—malignant glioma	0.00426	0.00769	CcSEcCtD
Nelarabine—Sepsis—Carmustine—malignant glioma	0.00423	0.00764	CcSEcCtD
Nelarabine—Mental disability—Carmustine—malignant glioma	0.00423	0.00764	CcSEcCtD
Nelarabine—DCK—Purine metabolism—CAT—malignant glioma	0.00421	0.0172	CbGpPWpGaD
Nelarabine—Mental disability—Temozolomide—malignant glioma	0.00409	0.00739	CcSEcCtD
Nelarabine—ADA—p73 transcription factor network—PLK1—malignant glioma	0.00408	0.0167	CbGpPWpGaD
Nelarabine—ADA—Validated transcriptional targets of TAp63 isoforms—JAG1—malignant glioma	0.00399	0.0163	CbGpPWpGaD
Nelarabine—ADA—p73 transcription factor network—WT1—malignant glioma	0.00386	0.0158	CbGpPWpGaD
Nelarabine—DCK—central nervous system—malignant glioma	0.00382	0.0207	CbGeAlD
Nelarabine—ADA—C-MYB transcription factor network—MYB—malignant glioma	0.00381	0.0156	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—RTEL1—malignant glioma	0.00381	0.0156	CbGpPWpGaD
Nelarabine—Amnesia—Carmustine—malignant glioma	0.00376	0.0068	CcSEcCtD
Nelarabine—DCK—cerebellum—malignant glioma	0.00373	0.0202	CbGeAlD
Nelarabine—ADA—p73 transcription factor network—JAG2—malignant glioma	0.00369	0.0151	CbGpPWpGaD
Nelarabine—Amnesia—Temozolomide—malignant glioma	0.00364	0.00658	CcSEcCtD
Nelarabine—ADA—Validated transcriptional targets of deltaNp63 isoforms—BRCA2—malignant glioma	0.00345	0.0141	CbGpPWpGaD
Nelarabine—ADA—p73 transcription factor network—PML—malignant glioma	0.00344	0.0141	CbGpPWpGaD
Nelarabine—POLA1—Retinoblastoma (RB) in Cancer—STMN1—malignant glioma	0.00336	0.0138	CbGpPWpGaD
Nelarabine—Ataxia—Carmustine—malignant glioma	0.00333	0.00601	CcSEcCtD
Nelarabine—ADA—Validated transcriptional targets of deltaNp63 isoforms—HES1—malignant glioma	0.00326	0.0133	CbGpPWpGaD
Nelarabine—Hypokalaemia—Carmustine—malignant glioma	0.00322	0.00582	CcSEcCtD
Nelarabine—Ataxia—Temozolomide—malignant glioma	0.00321	0.00581	CcSEcCtD
Nelarabine—ADA—Circadian rythm related genes—NTRK3—malignant glioma	0.00319	0.013	CbGpPWpGaD
Nelarabine—Dehydration—Temozolomide—malignant glioma	0.00318	0.00575	CcSEcCtD
Nelarabine—Muscular weakness—Carmustine—malignant glioma	0.00312	0.00564	CcSEcCtD
Nelarabine—Hypokalaemia—Temozolomide—malignant glioma	0.00311	0.00562	CcSEcCtD
Nelarabine—Aspartate aminotransferase increased—Temozolomide—malignant glioma	0.00308	0.00556	CcSEcCtD
Nelarabine—DCK—brain—malignant glioma	0.00303	0.0164	CbGeAlD
Nelarabine—Muscular weakness—Temozolomide—malignant glioma	0.00301	0.00545	CcSEcCtD
Nelarabine—Abdominal distension—Temozolomide—malignant glioma	0.00297	0.00538	CcSEcCtD
Nelarabine—Neutropenia—Carmustine—malignant glioma	0.00286	0.00517	CcSEcCtD
Nelarabine—POLA1—Extension of Telomeres—TERT—malignant glioma	0.00284	0.0116	CbGpPWpGaD
Nelarabine—Neutropenia—Temozolomide—malignant glioma	0.00276	0.00499	CcSEcCtD
Nelarabine—Hyperglycaemia—Carmustine—malignant glioma	0.00276	0.00498	CcSEcCtD
Nelarabine—Pneumonia—Carmustine—malignant glioma	0.00274	0.00496	CcSEcCtD
Nelarabine—Depression—Carmustine—malignant glioma	0.00272	0.00491	CcSEcCtD
Nelarabine—Adenosine triphosphate—AKT1—malignant glioma	0.00271	0.152	CrCbGaD
Nelarabine—DCK—Retinoblastoma (RB) in Cancer—TOP2A—malignant glioma	0.00269	0.011	CbGpPWpGaD
Nelarabine—Neuropathy peripheral—Carmustine—malignant glioma	0.00267	0.00483	CcSEcCtD
Nelarabine—Hyperglycaemia—Temozolomide—malignant glioma	0.00266	0.00482	CcSEcCtD
Nelarabine—Stomatitis—Carmustine—malignant glioma	0.00266	0.0048	CcSEcCtD
Nelarabine—Pneumonia—Temozolomide—malignant glioma	0.00265	0.00479	CcSEcCtD
Nelarabine—Infestation NOS—Temozolomide—malignant glioma	0.00263	0.00476	CcSEcCtD
Nelarabine—Infestation—Temozolomide—malignant glioma	0.00263	0.00476	CcSEcCtD
Nelarabine—Depression—Temozolomide—malignant glioma	0.00263	0.00475	CcSEcCtD
Nelarabine—Neuropathy peripheral—Temozolomide—malignant glioma	0.00258	0.00467	CcSEcCtD
Nelarabine—Stomatitis—Temozolomide—malignant glioma	0.00257	0.00464	CcSEcCtD
Nelarabine—Hepatobiliary disease—Temozolomide—malignant glioma	0.00249	0.0045	CcSEcCtD
Nelarabine—Sinusitis—Temozolomide—malignant glioma	0.00247	0.00447	CcSEcCtD
Nelarabine—ADA—Validated transcriptional targets of deltaNp63 isoforms—NOTCH1—malignant glioma	0.00246	0.0101	CbGpPWpGaD
Nelarabine—ADA—p73 transcription factor network—NTRK1—malignant glioma	0.00245	0.01	CbGpPWpGaD
Nelarabine—Hypoaesthesia—Carmustine—malignant glioma	0.00243	0.0044	CcSEcCtD
Nelarabine—Oedema peripheral—Carmustine—malignant glioma	0.00241	0.00436	CcSEcCtD
Nelarabine—Connective tissue disorder—Carmustine—malignant glioma	0.0024	0.00435	CcSEcCtD
Nelarabine—Hypoaesthesia—Temozolomide—malignant glioma	0.00235	0.00425	CcSEcCtD
Nelarabine—Urinary tract disorder—Temozolomide—malignant glioma	0.00233	0.00422	CcSEcCtD
Nelarabine—Oedema peripheral—Temozolomide—malignant glioma	0.00233	0.00421	CcSEcCtD
Nelarabine—Connective tissue disorder—Temozolomide—malignant glioma	0.00232	0.0042	CcSEcCtD
Nelarabine—Urethral disorder—Temozolomide—malignant glioma	0.00232	0.00419	CcSEcCtD
Nelarabine—ADA—Nucleotide metabolism—CAT—malignant glioma	0.00229	0.00937	CbGpPWpGaD
Nelarabine—Eye disorder—Carmustine—malignant glioma	0.00229	0.00413	CcSEcCtD
Nelarabine—ADA—p73 transcription factor network—BRCA2—malignant glioma	0.00228	0.00931	CbGpPWpGaD
Nelarabine—Eye disorder—Temozolomide—malignant glioma	0.00221	0.00399	CcSEcCtD
Nelarabine—Cardiac disorder—Temozolomide—malignant glioma	0.00219	0.00397	CcSEcCtD
Nelarabine—DGUOK—Metabolism—COX8A—malignant glioma	0.00219	0.00894	CbGpPWpGaD
Nelarabine—Angiopathy—Temozolomide—malignant glioma	0.00215	0.00388	CcSEcCtD
Nelarabine—Mental disorder—Carmustine—malignant glioma	0.00214	0.00387	CcSEcCtD
Nelarabine—Mediastinal disorder—Temozolomide—malignant glioma	0.00213	0.00385	CcSEcCtD
Nelarabine—Malnutrition—Carmustine—malignant glioma	0.00213	0.00385	CcSEcCtD
Nelarabine—Chills—Temozolomide—malignant glioma	0.00212	0.00383	CcSEcCtD
Nelarabine—DCK—Nucleotide metabolism—CAT—malignant glioma	0.00211	0.00864	CbGpPWpGaD
Nelarabine—Mental disorder—Temozolomide—malignant glioma	0.00207	0.00374	CcSEcCtD
Nelarabine—Back pain—Carmustine—malignant glioma	0.00206	0.00372	CcSEcCtD
Nelarabine—Malnutrition—Temozolomide—malignant glioma	0.00206	0.00372	CcSEcCtD
Nelarabine—ADA—C-MYB transcription factor network—HES1—malignant glioma	0.00205	0.00838	CbGpPWpGaD
Nelarabine—ADA—C-MYB transcription factor network—NCOR1—malignant glioma	0.00204	0.00834	CbGpPWpGaD
Nelarabine—Dysgeusia—Temozolomide—malignant glioma	0.00202	0.00364	CcSEcCtD
Nelarabine—Vision blurred—Carmustine—malignant glioma	0.00201	0.00363	CcSEcCtD
Nelarabine—Tremor—Carmustine—malignant glioma	0.002	0.00361	CcSEcCtD
Nelarabine—Back pain—Temozolomide—malignant glioma	0.00199	0.0036	CcSEcCtD
Nelarabine—POLA1—Retinoblastoma (RB) in Cancer—TOP2A—malignant glioma	0.00197	0.00805	CbGpPWpGaD
Nelarabine—Anaemia—Carmustine—malignant glioma	0.00197	0.00356	CcSEcCtD
Nelarabine—ADA—Validated transcriptional targets of deltaNp63 isoforms—CDKN2A—malignant glioma	0.00196	0.008	CbGpPWpGaD
Nelarabine—Vision blurred—Temozolomide—malignant glioma	0.00194	0.00351	CcSEcCtD
Nelarabine—Tremor—Temozolomide—malignant glioma	0.00193	0.00349	CcSEcCtD
Nelarabine—Leukopenia—Carmustine—malignant glioma	0.00191	0.00345	CcSEcCtD
Nelarabine—Anaemia—Temozolomide—malignant glioma	0.0019	0.00344	CcSEcCtD
Nelarabine—ADA—Validated transcriptional targets of deltaNp63 isoforms—MDM2—malignant glioma	0.0019	0.00776	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—ASMT—malignant glioma	0.00186	0.00761	CbGpPWpGaD
Nelarabine—Convulsion—Carmustine—malignant glioma	0.00185	0.00334	CcSEcCtD
Nelarabine—Leukopenia—Temozolomide—malignant glioma	0.00184	0.00333	CcSEcCtD
Nelarabine—Myalgia—Carmustine—malignant glioma	0.00181	0.00328	CcSEcCtD
Nelarabine—Chest pain—Carmustine—malignant glioma	0.00181	0.00328	CcSEcCtD
Nelarabine—Cough—Temozolomide—malignant glioma	0.0018	0.00325	CcSEcCtD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—STMN1—malignant glioma	0.00179	0.00733	CbGpPWpGaD
Nelarabine—Convulsion—Temozolomide—malignant glioma	0.00178	0.00322	CcSEcCtD
Nelarabine—Confusional state—Carmustine—malignant glioma	0.00175	0.00317	CcSEcCtD
Nelarabine—Myalgia—Temozolomide—malignant glioma	0.00175	0.00317	CcSEcCtD
Nelarabine—Arthralgia—Temozolomide—malignant glioma	0.00175	0.00317	CcSEcCtD
Nelarabine—ADA—Validated transcriptional targets of TAp63 isoforms—CDKN2A—malignant glioma	0.00175	0.00716	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—BCAN—malignant glioma	0.00175	0.00715	CbGpPWpGaD
Nelarabine—Oedema—Carmustine—malignant glioma	0.00174	0.00314	CcSEcCtD
Nelarabine—Infection—Carmustine—malignant glioma	0.00173	0.00312	CcSEcCtD
Nelarabine—Thrombocytopenia—Carmustine—malignant glioma	0.0017	0.00308	CcSEcCtD
Nelarabine—ADA—Validated transcriptional targets of TAp63 isoforms—MDM2—malignant glioma	0.0017	0.00694	CbGpPWpGaD
Nelarabine—Confusional state—Temozolomide—malignant glioma	0.00169	0.00306	CcSEcCtD
Nelarabine—Oedema—Temozolomide—malignant glioma	0.00168	0.00304	CcSEcCtD
Nelarabine—Infection—Temozolomide—malignant glioma	0.00167	0.00302	CcSEcCtD
Nelarabine—Anorexia—Carmustine—malignant glioma	0.00166	0.003	CcSEcCtD
Nelarabine—Nervous system disorder—Temozolomide—malignant glioma	0.00165	0.00298	CcSEcCtD
Nelarabine—Thrombocytopenia—Temozolomide—malignant glioma	0.00164	0.00297	CcSEcCtD
Nelarabine—ADA—Circadian rythm related genes—PML—malignant glioma	0.00163	0.00667	CbGpPWpGaD
Nelarabine—Hypotension—Carmustine—malignant glioma	0.00162	0.00294	CcSEcCtD
Nelarabine—Anorexia—Temozolomide—malignant glioma	0.0016	0.00289	CcSEcCtD
Nelarabine—Musculoskeletal discomfort—Carmustine—malignant glioma	0.00158	0.00286	CcSEcCtD
Nelarabine—Insomnia—Carmustine—malignant glioma	0.00157	0.00284	CcSEcCtD
Nelarabine—Paraesthesia—Carmustine—malignant glioma	0.00156	0.00282	CcSEcCtD
Nelarabine—Dyspnoea—Carmustine—malignant glioma	0.00155	0.0028	CcSEcCtD
Nelarabine—Somnolence—Carmustine—malignant glioma	0.00155	0.00279	CcSEcCtD
Nelarabine—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.00153	0.00277	CcSEcCtD
Nelarabine—Insomnia—Temozolomide—malignant glioma	0.00152	0.00275	CcSEcCtD
Nelarabine—Decreased appetite—Carmustine—malignant glioma	0.00151	0.00273	CcSEcCtD
Nelarabine—Paraesthesia—Temozolomide—malignant glioma	0.00151	0.00273	CcSEcCtD
Nelarabine—Gastrointestinal disorder—Carmustine—malignant glioma	0.0015	0.00271	CcSEcCtD
Nelarabine—Dyspnoea—Temozolomide—malignant glioma	0.0015	0.00271	CcSEcCtD
Nelarabine—Somnolence—Temozolomide—malignant glioma	0.00149	0.0027	CcSEcCtD
Nelarabine—ADA—Circadian rythm related genes—TOP2A—malignant glioma	0.00149	0.0061	CbGpPWpGaD
Nelarabine—Pain—Carmustine—malignant glioma	0.00149	0.00269	CcSEcCtD
Nelarabine—Constipation—Carmustine—malignant glioma	0.00149	0.00269	CcSEcCtD
Nelarabine—Decreased appetite—Temozolomide—malignant glioma	0.00146	0.00264	CcSEcCtD
Nelarabine—Gastrointestinal disorder—Temozolomide—malignant glioma	0.00145	0.00262	CcSEcCtD
Nelarabine—Fatigue—Temozolomide—malignant glioma	0.00145	0.00262	CcSEcCtD
Nelarabine—Constipation—Temozolomide—malignant glioma	0.00144	0.0026	CcSEcCtD
Nelarabine—Pain—Temozolomide—malignant glioma	0.00144	0.0026	CcSEcCtD
Nelarabine—Feeling abnormal—Carmustine—malignant glioma	0.00143	0.00259	CcSEcCtD
Nelarabine—POLA1—Cell Cycle, Mitotic—TUBG2—malignant glioma	0.00143	0.00586	CbGpPWpGaD
Nelarabine—Gastrointestinal pain—Carmustine—malignant glioma	0.00142	0.00257	CcSEcCtD
Nelarabine—DGUOK—Metabolism—IDH2—malignant glioma	0.00141	0.00576	CbGpPWpGaD
Nelarabine—POLA1—Mitotic G1-G1/S phases—TOP2A—malignant glioma	0.00139	0.00567	CbGpPWpGaD
Nelarabine—Feeling abnormal—Temozolomide—malignant glioma	0.00138	0.0025	CcSEcCtD
Nelarabine—Body temperature increased—Carmustine—malignant glioma	0.00137	0.00248	CcSEcCtD
Nelarabine—Abdominal pain—Carmustine—malignant glioma	0.00137	0.00248	CcSEcCtD
Nelarabine—Gastrointestinal pain—Temozolomide—malignant glioma	0.00137	0.00248	CcSEcCtD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—PLK1—malignant glioma	0.00136	0.00556	CbGpPWpGaD
Nelarabine—Body temperature increased—Temozolomide—malignant glioma	0.00133	0.0024	CcSEcCtD
Nelarabine—Abdominal pain—Temozolomide—malignant glioma	0.00133	0.0024	CcSEcCtD
Nelarabine—DGUOK—Metabolism—CYP2B6—malignant glioma	0.00132	0.00542	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—WT1—malignant glioma	0.00129	0.00527	CbGpPWpGaD
Nelarabine—POLA1—Telomere Maintenance—TERT—malignant glioma	0.00129	0.00527	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle—TUBG2—malignant glioma	0.00128	0.00524	CbGpPWpGaD
Nelarabine—ADA—Metabolism—RTEL1—malignant glioma	0.00126	0.00517	CbGpPWpGaD
Nelarabine—ADA—p73 transcription factor network—MDM2—malignant glioma	0.00125	0.00512	CbGpPWpGaD
Nelarabine—Asthenia—Carmustine—malignant glioma	0.00125	0.00225	CcSEcCtD
Nelarabine—ADA—C-MYB transcription factor network—CDKN2A—malignant glioma	0.00123	0.00503	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—IDH1—malignant glioma	0.00121	0.00496	CbGpPWpGaD
Nelarabine—ADA—C-MYB transcription factor network—BCL2—malignant glioma	0.00121	0.00495	CbGpPWpGaD
Nelarabine—Asthenia—Temozolomide—malignant glioma	0.00121	0.00218	CcSEcCtD
Nelarabine—Diarrhoea—Carmustine—malignant glioma	0.00119	0.00215	CcSEcCtD
Nelarabine—DGUOK—Metabolism—SPHK1—malignant glioma	0.00117	0.0048	CbGpPWpGaD
Nelarabine—DCK—Metabolism—RTEL1—malignant glioma	0.00117	0.00477	CbGpPWpGaD
Nelarabine—ADA—Circadian rythm related genes—NTRK1—malignant glioma	0.00116	0.00475	CbGpPWpGaD
Nelarabine—Dizziness—Carmustine—malignant glioma	0.00115	0.00208	CcSEcCtD
Nelarabine—Diarrhoea—Temozolomide—malignant glioma	0.00115	0.00208	CcSEcCtD
Nelarabine—ADA—C-MYB transcription factor network—PTGS2—malignant glioma	0.00115	0.0047	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—CYP2C18—malignant glioma	0.00115	0.0047	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—PML—malignant glioma	0.00115	0.00469	CbGpPWpGaD
Nelarabine—Dizziness—Temozolomide—malignant glioma	0.00111	0.00201	CcSEcCtD
Nelarabine—Vomiting—Carmustine—malignant glioma	0.00111	0.002	CcSEcCtD
Nelarabine—Headache—Carmustine—malignant glioma	0.00109	0.00197	CcSEcCtD
Nelarabine—POLA1—Chromosome Maintenance—TERT—malignant glioma	0.00107	0.00439	CbGpPWpGaD
Nelarabine—DCK—Retinoblastoma (RB) in Cancer—MDM2—malignant glioma	0.00107	0.00437	CbGpPWpGaD
Nelarabine—Vomiting—Temozolomide—malignant glioma	0.00107	0.00193	CcSEcCtD
Nelarabine—DCK—Retinoblastoma (RB) in Cancer—RAF1—malignant glioma	0.00107	0.00436	CbGpPWpGaD
Nelarabine—Headache—Temozolomide—malignant glioma	0.00105	0.0019	CcSEcCtD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—TOP2A—malignant glioma	0.00105	0.00429	CbGpPWpGaD
Nelarabine—Nausea—Carmustine—malignant glioma	0.00103	0.00187	CcSEcCtD
Nelarabine—ADA—Circadian rythm related genes—NCOR1—malignant glioma	0.00101	0.00415	CbGpPWpGaD
Nelarabine—Nausea—Temozolomide—malignant glioma	0.000998	0.0018	CcSEcCtD
Nelarabine—POLA1—Mitotic G1-G1/S phases—CDKN2B—malignant glioma	0.000993	0.00406	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—GSTT1—malignant glioma	0.000929	0.0038	CbGpPWpGaD
Nelarabine—POLA1—E2F transcription factor network—CDKN2A—malignant glioma	0.000929	0.0038	CbGpPWpGaD
Nelarabine—POLA1—Mitotic M-M/G1 phases—PLK1—malignant glioma	0.000879	0.0036	CbGpPWpGaD
Nelarabine—ADA—p73 transcription factor network—MYC—malignant glioma	0.000875	0.00358	CbGpPWpGaD
Nelarabine—POLA1—Mitotic M-M/G1 phases—HIST1H3B—malignant glioma	0.000871	0.00356	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—PTGS1—malignant glioma	0.000871	0.00356	CbGpPWpGaD
Nelarabine—ADA—C-MYB transcription factor network—MYC—malignant glioma	0.000833	0.00341	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—NTRK1—malignant glioma	0.000816	0.00334	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—BCHE—malignant glioma	0.000809	0.00331	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—SLC5A5—malignant glioma	0.000799	0.00327	CbGpPWpGaD
Nelarabine—POLA1—Retinoblastoma (RB) in Cancer—MDM2—malignant glioma	0.000783	0.0032	CbGpPWpGaD
Nelarabine—POLA1—Retinoblastoma (RB) in Cancer—RAF1—malignant glioma	0.00078	0.00319	CbGpPWpGaD
Nelarabine—ADA—C-MYB transcription factor network—KRAS—malignant glioma	0.000769	0.00315	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—BRCA2—malignant glioma	0.000759	0.0031	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—CDKN2B—malignant glioma	0.000752	0.00308	CbGpPWpGaD
Nelarabine—DCK—Retinoblastoma (RB) in Cancer—MYC—malignant glioma	0.000747	0.00306	CbGpPWpGaD
Nelarabine—ADA—Circadian rythm related genes—PPARG—malignant glioma	0.000727	0.00297	CbGpPWpGaD
Nelarabine—ADA—Metabolism—COX8A—malignant glioma	0.000726	0.00297	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—PDGFRA—malignant glioma	0.000683	0.00279	CbGpPWpGaD
Nelarabine—POLA1—Mitotic M-M/G1 phases—H3F3A—malignant glioma	0.000673	0.00275	CbGpPWpGaD
Nelarabine—DCK—Metabolism—COX8A—malignant glioma	0.00067	0.00274	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle, Mitotic—PLK1—malignant glioma	0.000658	0.00269	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle, Mitotic—HIST1H3B—malignant glioma	0.000651	0.00266	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—GSTP1—malignant glioma	0.000644	0.00263	CbGpPWpGaD
Nelarabine—POLA1—E2F transcription factor network—MYC—malignant glioma	0.000629	0.00257	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—CAT—malignant glioma	0.000627	0.00256	CbGpPWpGaD
Nelarabine—ADA—Metabolism—ASMT—malignant glioma	0.000617	0.00252	CbGpPWpGaD
Nelarabine—DCK—Retinoblastoma (RB) in Cancer—TP53—malignant glioma	0.000614	0.00251	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—FGFR1—malignant glioma	0.000611	0.0025	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—NCOR1—malignant glioma	0.000592	0.00242	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle—PLK1—malignant glioma	0.000588	0.0024	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle—HIST1H3B—malignant glioma	0.000582	0.00238	CbGpPWpGaD
Nelarabine—ADA—Metabolism—BCAN—malignant glioma	0.00058	0.00237	CbGpPWpGaD
Nelarabine—DCK—Metabolism—ASMT—malignant glioma	0.00057	0.00233	CbGpPWpGaD
Nelarabine—POLA1—Mitotic G1-G1/S phases—CDKN2A—malignant glioma	0.000568	0.00232	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—BAD—malignant glioma	0.000547	0.00224	CbGpPWpGaD
Nelarabine—POLA1—Retinoblastoma (RB) in Cancer—MYC—malignant glioma	0.000547	0.00224	CbGpPWpGaD
Nelarabine—DCK—Metabolism—BCAN—malignant glioma	0.000536	0.00219	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—APC—malignant glioma	0.00053	0.00217	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—EGF—malignant glioma	0.000524	0.00214	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle, Mitotic—TOP2A—malignant glioma	0.000508	0.00208	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle, Mitotic—H3F3A—malignant glioma	0.000503	0.00206	CbGpPWpGaD
Nelarabine—ADA—Circadian rythm related genes—PTEN—malignant glioma	0.000499	0.00204	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle, Mitotic—YWHAE—malignant glioma	0.000485	0.00198	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—CAV1—malignant glioma	0.000482	0.00197	CbGpPWpGaD
Nelarabine—ADA—Metabolism—IDH2—malignant glioma	0.000468	0.00191	CbGpPWpGaD
Nelarabine—POLA1—G1/S Transition—MYC—malignant glioma	0.000457	0.00187	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle—TOP2A—malignant glioma	0.000454	0.00186	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle—H3F3A—malignant glioma	0.00045	0.00184	CbGpPWpGaD
Nelarabine—POLA1—Retinoblastoma (RB) in Cancer—TP53—malignant glioma	0.000449	0.00184	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—FGF2—malignant glioma	0.000446	0.00182	CbGpPWpGaD
Nelarabine—ADA—Metabolism—CYP2B6—malignant glioma	0.00044	0.0018	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—PIK3CG—malignant glioma	0.000439	0.0018	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle—YWHAE—malignant glioma	0.000433	0.00177	CbGpPWpGaD
Nelarabine—DCK—Metabolism—IDH2—malignant glioma	0.000432	0.00177	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—PPARG—malignant glioma	0.000424	0.00173	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—BCL2—malignant glioma	0.000423	0.00173	CbGpPWpGaD
Nelarabine—POLA1—Mitotic M-M/G1 phases—BIRC5—malignant glioma	0.00042	0.00172	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—MDM2—malignant glioma	0.000417	0.00171	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—RAF1—malignant glioma	0.000416	0.0017	CbGpPWpGaD
Nelarabine—POLA1—S Phase—MYC—malignant glioma	0.000415	0.0017	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—ERBB2—malignant glioma	0.000411	0.00168	CbGpPWpGaD
Nelarabine—DCK—Metabolism—CYP2B6—malignant glioma	0.000406	0.00166	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—PTGS2—malignant glioma	0.000402	0.00165	CbGpPWpGaD
Nelarabine—ADA—Metabolism—IDH1—malignant glioma	0.000402	0.00165	CbGpPWpGaD
Nelarabine—ADA—Metabolism—SPHK1—malignant glioma	0.000389	0.00159	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—PIK3CD—malignant glioma	0.000386	0.00158	CbGpPWpGaD
Nelarabine—POLA1—Mitotic G1-G1/S phases—MYC—malignant glioma	0.000385	0.00157	CbGpPWpGaD
Nelarabine—ADA—Metabolism—CYP2C18—malignant glioma	0.000381	0.00156	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—CASP3—malignant glioma	0.000373	0.00153	CbGpPWpGaD
Nelarabine—DCK—Metabolism—IDH1—malignant glioma	0.000371	0.00152	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle, Mitotic—CDKN2B—malignant glioma	0.000364	0.00149	CbGpPWpGaD
Nelarabine—DCK—Metabolism—SPHK1—malignant glioma	0.000359	0.00147	CbGpPWpGaD
Nelarabine—DCK—Metabolism—CYP2C18—malignant glioma	0.000352	0.00144	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—PTEN—malignant glioma	0.000351	0.00143	CbGpPWpGaD
Nelarabine—ADA—Circadian rythm related genes—TP53—malignant glioma	0.00034	0.00139	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—PIK3CB—malignant glioma	0.000337	0.00138	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—PTGS2—malignant glioma	0.000334	0.00136	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle—BRCA2—malignant glioma	0.000329	0.00134	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle—CDKN2B—malignant glioma	0.000326	0.00133	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—VEGFA—malignant glioma	0.000317	0.0013	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle, Mitotic—BIRC5—malignant glioma	0.000314	0.00129	CbGpPWpGaD
Nelarabine—ADA—Metabolism—GSTT1—malignant glioma	0.000308	0.00126	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—MYC—malignant glioma	0.000292	0.00119	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—PTEN—malignant glioma	0.000291	0.00119	CbGpPWpGaD
Nelarabine—ADA—Metabolism—PTGS1—malignant glioma	0.000289	0.00118	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—EGFR—malignant glioma	0.000285	0.00117	CbGpPWpGaD
Nelarabine—DCK—Metabolism—GSTT1—malignant glioma	0.000285	0.00116	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle—BIRC5—malignant glioma	0.000281	0.00115	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle—TERT—malignant glioma	0.000272	0.00111	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—TNF—malignant glioma	0.000272	0.00111	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—KRAS—malignant glioma	0.000269	0.0011	CbGpPWpGaD
Nelarabine—ADA—Metabolism—BCHE—malignant glioma	0.000269	0.0011	CbGpPWpGaD
Nelarabine—DCK—Metabolism—PTGS1—malignant glioma	0.000267	0.00109	CbGpPWpGaD
Nelarabine—ADA—Metabolism—SLC5A5—malignant glioma	0.000265	0.00109	CbGpPWpGaD
Nelarabine—DCK—Metabolism—BCHE—malignant glioma	0.000248	0.00101	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—PIK3CA—malignant glioma	0.000247	0.00101	CbGpPWpGaD
Nelarabine—DCK—Metabolism—SLC5A5—malignant glioma	0.000245	0.001	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—TP53—malignant glioma	0.000239	0.000979	CbGpPWpGaD
Nelarabine—ADA—Metabolism—GSTP1—malignant glioma	0.000214	0.000874	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle, Mitotic—CDKN2A—malignant glioma	0.000208	0.000852	CbGpPWpGaD
Nelarabine—ADA—Metabolism—CAT—malignant glioma	0.000208	0.000851	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—PIK3CA—malignant glioma	0.000205	0.00084	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—AKT1—malignant glioma	0.000202	0.000827	CbGpPWpGaD
Nelarabine—DCK—Metabolism—GSTP1—malignant glioma	0.000197	0.000807	CbGpPWpGaD
Nelarabine—ADA—Metabolism—NCOR1—malignant glioma	0.000196	0.000804	CbGpPWpGaD
Nelarabine—DCK—Metabolism—CAT—malignant glioma	0.000192	0.000785	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle—CDKN2A—malignant glioma	0.000186	0.000762	CbGpPWpGaD
Nelarabine—DCK—Metabolism—NCOR1—malignant glioma	0.000181	0.000742	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle—MDM2—malignant glioma	0.000181	0.000739	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—AKT1—malignant glioma	0.000168	0.000686	CbGpPWpGaD
Nelarabine—ADA—Metabolism—CAV1—malignant glioma	0.00016	0.000655	CbGpPWpGaD
Nelarabine—DCK—Metabolism—CAV1—malignant glioma	0.000148	0.000604	CbGpPWpGaD
Nelarabine—ADA—Metabolism—PIK3CG—malignant glioma	0.000146	0.000597	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle, Mitotic—MYC—malignant glioma	0.000141	0.000577	CbGpPWpGaD
Nelarabine—ADA—Metabolism—PPARG—malignant glioma	0.000141	0.000576	CbGpPWpGaD
Nelarabine—DCK—Metabolism—PIK3CG—malignant glioma	0.000135	0.000551	CbGpPWpGaD
Nelarabine—DCK—Metabolism—PPARG—malignant glioma	0.00013	0.000531	CbGpPWpGaD
Nelarabine—ADA—Metabolism—PIK3CD—malignant glioma	0.000128	0.000525	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle—MYC—malignant glioma	0.000126	0.000516	CbGpPWpGaD
Nelarabine—DCK—Metabolism—PIK3CD—malignant glioma	0.000118	0.000484	CbGpPWpGaD
Nelarabine—ADA—Metabolism—PIK3CB—malignant glioma	0.000112	0.000457	CbGpPWpGaD
Nelarabine—ADA—Metabolism—PTGS2—malignant glioma	0.000111	0.000453	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle—TP53—malignant glioma	0.000104	0.000424	CbGpPWpGaD
Nelarabine—DCK—Metabolism—PIK3CB—malignant glioma	0.000103	0.000422	CbGpPWpGaD
Nelarabine—DCK—Metabolism—PTGS2—malignant glioma	0.000102	0.000418	CbGpPWpGaD
Nelarabine—ADA—Metabolism—PTEN—malignant glioma	9.66e-05	0.000395	CbGpPWpGaD
Nelarabine—DCK—Metabolism—PTEN—malignant glioma	8.91e-05	0.000365	CbGpPWpGaD
Nelarabine—ADA—Metabolism—PIK3CA—malignant glioma	6.81e-05	0.000279	CbGpPWpGaD
Nelarabine—DCK—Metabolism—PIK3CA—malignant glioma	6.29e-05	0.000257	CbGpPWpGaD
Nelarabine—ADA—Metabolism—AKT1—malignant glioma	5.57e-05	0.000228	CbGpPWpGaD
Nelarabine—DCK—Metabolism—AKT1—malignant glioma	5.14e-05	0.00021	CbGpPWpGaD
